Sponsor: University of Michigan Rogel Cancer Center
Sex: All
Age: 18+
Code: NCT06927947
Recruiting
ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial